chr19-44907785-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_000041.4(APOE):c.69G>A(p.Ala23Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00029 in 1,612,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000041.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOE | NM_000041.4 | c.69G>A | p.Ala23Ala | synonymous_variant | Exon 3 of 4 | ENST00000252486.9 | NP_000032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOE | ENST00000252486.9 | c.69G>A | p.Ala23Ala | synonymous_variant | Exon 3 of 4 | 1 | NM_000041.4 | ENSP00000252486.3 | ||
APOE | ENST00000425718.1 | c.69G>A | p.Ala23Ala | synonymous_variant | Exon 2 of 3 | 1 | ENSP00000410423.1 | |||
APOE | ENST00000434152.5 | c.147G>A | p.Ala49Ala | synonymous_variant | Exon 3 of 4 | 2 | ENSP00000413653.2 | |||
APOE | ENST00000446996.5 | c.69G>A | p.Ala23Ala | synonymous_variant | Exon 3 of 4 | 2 | ENSP00000413135.1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000202 AC: 50AN: 247950Hom.: 0 AF XY: 0.000231 AC XY: 31AN XY: 134398
GnomAD4 exome AF: 0.000296 AC: 432AN: 1460598Hom.: 0 Cov.: 32 AF XY: 0.000299 AC XY: 217AN XY: 726604
GnomAD4 genome AF: 0.000230 AC: 35AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74354
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Familial type 3 hyperlipoproteinemia;C0036489:Sea-blue histiocyte syndrome;C1843013:Alzheimer disease 3;C1847200:Alzheimer disease 4;C1863051:Alzheimer disease 2;C1864205:Age related macular degeneration 1;C2673196:Lipoprotein glomerulopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at